Summary
- The biotech sector has been extremely weak to begin this week and a lot of investors are asking whether this is the start of a larger swoon in this space.
- I don’t have a definitive answer to that question but there are a couple of things I am watching to determine the near-term direction of this sector.
- Below is my game plan as the biotech sector seems to be entering a period of escalating volatility.
